Search Within


Applied Filters:
Showing 1-8 of 8 results for "SAB4500823" within Papers
Zhuang-Zhuang Tang et al.
Naunyn-Schmiedeberg's archives of pharmacology (2021-11-19)
Upregulation of thrombin receptor protease-activated receptor 1 (PAR-1) is verified to contribute to chronic kidney diseases, including diabetic nephropathy; however, the mechanisms are still unclear. In this study, we investigated the effect of PAR-1 on high glucose-induced proliferation of human
Potential importance of protease activated receptor (PAR)-1 expression in the tumor stroma of non-small-cell lung cancer.
Lin C, et al.
BMC Cancer, 17(1), 113-113 (2017)
Uncoupling of the profibrotic and hemostatic effects of thrombin in lung fibrosis.
Shea B S, et al.
JCI insight, 2(9) (2017)
Barry S Shea et al.
JCI insight, 2(9) (2017-05-05)
Fibrotic lung disease, most notably idiopathic pulmonary fibrosis (IPF), is thought to result from aberrant wound-healing responses to repetitive lung injury. Increased vascular permeability is a cardinal response to tissue injury, but whether it is mechanistically linked to lung fibrosis
Li Kong et al.
Fundamental & clinical pharmacology, 36(3), 509-517 (2021-12-15)
Thrombin activity enhancement and its receptor protease-activated receptor 1 (PAR-1) activation play vital roles in neurologic deficits in the central nervous system. Our recent study showed that PAR-1 upregulation stimulated by chronic high glucose (HG) caused central neuron injury through
The protease activated receptor 1 gene variation IVSn?14 A> T is associated with distant metastasis and cancer specific survival in renal cell carcinoma.
de Martino M, et al.
The Journal of Urology, 190(4), 1392-1397 (2013)
Role of a functional polymorphism in the F2R gene promoter in sarcoidosis.
Plate M, et al.
Respirology, 20(8), 1285-1287 (2015)
A novel protease-activated receptor-1 interactor, Bicaudal D1, regulates G protein signaling and internalization.
Swift S, et al.
The Journal of Biological Chemistry, 285(15), 11402-11410 (2010)
Page 1 of 1